Companies / vTv Therapeutics Inc.

vTv Therapeutics Inc.

Nasdaq: VTVTCIK 1641489HIGH POINT, NC

Financials · FY2025

Revenue$0
Net income$-31.08M
Total debt$5.30M
Cash$86.64M
Diluted EPS
Shares outstanding4.0M

Ownership

4.0M shares outstanding · as of Aug 6, 2026
38.7%Institutions
Ownership
Institutions38.71%1,530,731
Public float61.29%2,423,197

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
667, L.P.Director
Baker FelixDirector
Baker JulianDirector
Sekhri Paul JCEOPres, CEO and Exec Chairperson · Director

Institutional holders 32

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 26, 2026Akkaraju Srinivas
Director
GrantDirector stock option (right to buy)+6K
+54.63%
16,983
0.43% of shares
low
Jun 26, 2026Spiegelman Daniel K
Director
GrantDirector stock option (right to buy)+6K
+60.00%
16,000
0.40% of shares
low
Jun 26, 2026Baker Bros. Advisors LP
Director
GrantNon-Qualified Stock Option (right to buy)+6K
6,000
0.15% of shares
low
Jun 26, 2026Baker Bros. Advisors LP
Director
GrantNon-Qualified Stock Option (right to buy)+6K
6,000
0.15% of shares
low
Feb 17, 2026Tung Michael Stephen
Executive
GrantEmployee stock option (right to buy)+45K
+99.93%
89,969
2.28% of shares
low
Feb 17, 2026Sekhri Paul J
CEO
GrantClass A Common Stock+140K
+55.51%
392,212
9.92% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Millennium Management LLCPassive13G
Millennium Management LLCPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
VTVT918385204